Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,265.6
5.6 (0.17%)

 

  • STI Straits Times Index
    3,265.6
    5.6 (0.17%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,520.5
    4.5 (0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,606.5
    -200.5 (-0.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,396.1
    1.8 (0.05%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 331.3M
  • Value: 686.5M
  • Rise: 115
  • Fall: 120
  • Unch: 533

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.082-
Singtel2.480-0.020
Genting Sing0.725-
AusGroup0.020-0.001
Keppel Corp5.640+0.350
Jiutian Chemical0.085+0.002
Thomson Medical0.082+0.001
CapLand IntCom T1.970+0.010
Mapletree Com Tr1.830-0.020
Mapletree NAC Tr1.080-0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,352.8 -189.3
HSI 23,606.5 -200.6
HSCEI 8,221.6 -69.7
Jakarta 6,610.3 -0.8
Nikkei 225 26,170.3 -841.0
SSE Comp 3,396.1 +1.8
Shanghai A 3,558.9 +1.9
Shanghai B 282.2 +3.1
KOSPI 2,661.7 +47.2

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

News - Detailed News Story

CFM: Change - Announcement of Appointment :: APPOINTMENT OF INDEPENDENT DIRECTOR

29 Oct 2021 22:53

Change - Announcement of Appointment :: APPOINTMENT OF INDEPENDENT DIRECTOR

Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast Oct 29, 2021 22:53
Status New
Announcement Sub Title APPOINTMENT OF INDEPENDENT DIRECTOR
Announcement Reference SG211029OTHROR6O
Submitted By (Co./ Ind. Name) Tan Wee Sin
Designation Company Secretary
Description (Please provide a detailed description of the event in the box below) This announcement has been reviewed by the Company's sponsor, Asian Corporate Advisors Pte. Ltd. ("the Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited ("the Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Foo Quee Yin at 160 Robinson Road, #21-05 SBF Center, Singapore 068914, Telephone number: 6221 0271

Additional Details
Date Of Appointment 29/10/2021
Name Of Person Teo Kian Huat
Age 49
Country Of Principal Residence Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) The Board (saved for Mr. Lo), taking into consideration the academic and professional qualifications, expertise, working experience and knowledge of Mr. Teo Kian Huat, and is satisfied that Mr. Teo Kian Huat possess the requisite competencies and experience to assume the responsibilities as a Non-Executive Independent Director, a member of the Nominating Committee, Audit Committee and Remuneration Committee of the Company.

The NC is of the view that there should be a strong element of independence at the Board level, especially in the light of the ongoing Sing-Swe MM Biotechnology Pte. Ltd. ("SSMM") acquisition. As such, the NC has not recommended or endorsed the appointment of this candidate due to (a) lack of experience as a listed company director; and (b) he was recommended for appointment by the introducer of the SSMM acquisition.

The Board (saved for Mr. Lo) considers Mr. Teo Kian Huat to be independent pursuant to Catalist Rule 704(7).
Whether appointment is executive, and if so, the area of responsibility Non-Executive Independent Director
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Non-Executive Independent Director; NC Member, AC Member and RC Member.
Professional qualifications Bachelor of Accountancy Degree, Nanyang Technological University
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries No
Conflict of interests (including any competing business) No
Working experience and occupation(s) during the past 10 years September 2021 to current
iCapital Holdings (SG) Pte Ltd
Senior Director

April 2019 to August 2021
ZACD Capital Pte. Ltd.
Executive Director

September 2018 to March 2019
Carrington RHT Investments Pte. Ltd. (formerly known as RH Investments Pte. Ltd.)
Managing Director

January 2018 to March 2019
RHT Strategic Advisory Pte. Ltd.
Advisor

May 2010 to December 2017
Accion Capital Management Pte. Ltd.
Partner
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) Yes
Shareholding interest in the listed issuer and its subsidiaries? No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years) Accion Capital Management Pte. Ltd.
Carrington RHT Investments Pte. Ltd.
ZACD Capital Pte. Ltd.
Bixbite Pte. Ltd.
Bridge Trust Pte. Ltd.
Laserblue Holdings Pte. Ltd.
Neptunite Holdings Pte. Ltd.
Golden Axis Pte. Ltd.
Present Anthea Holdings Pte. Ltd.
Anthea Holdings 1 Pte. Ltd.
Pivot Medical Pte. Ltd.
One Raffles Partners LLP
Soleil Capital Limited
Red Eminent Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No
(c) Whether there is any unsatisfied judgment against him? No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No
Any prior experience as a director of an issuer listed on the Exchange? No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange Mr. Teo Kian Huat will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange.
Source: SGXNet
Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.